Evidation Health

by Evidation Health  · Based in United States → — Multimodal real-world data for better decisions, built on direct connections to people
autoimmune cardiology-ai dermatology-ai

Documentation ProvidedRegulatory Status Disclosed

Overview

Evidation Health connects directly with millions of individuals to collect continuous, multimodal real-world health data. This data is transformed into scientific insights that inform model development and reveal disease progression, treatment experience, and real-world outcomes. Unlike traditional real-world data sources that primarily reflect clinical encounters, Evidation’s approach captures how patients manage conditions, experience treatment, and change between visits, providing a more comprehensive and temporal understanding of health.

The platform integrates various data types, including clinical data (EHR and claims), demographic and social context, conditions and treatment experience, patient-reported outcomes, molecular data from biosamples, and digital measures from wearables. This rich, longitudinal dataset supports a wide range of applications for life sciences companies, from research, discovery, and early development to evidence generation, medical value demonstration, and commercial planning.

Evidation maintains continuous, direct engagement with a large, diverse, and recontactable community of 5 million individuals across 97% of U.S. ZIP codes. This community participates in consented, mutual value exchange, generating contextualized, longitudinal real-world data that reflects how patients experience health, treatment, and disease in everyday life. The company has supported over 140 real-world studies and contributed to more than 100 peer-reviewed publications, partnering with 90% of the top biopharma companies.

For physicians and researchers, Evidation’s data can provide invaluable insights into disease progression, treatment effectiveness in real-world settings, and patient behaviors outside of clinical visits. This can inform clinical research, aid in understanding unmet needs, and contribute to the development of more patient-centered therapies and health programs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Continuous, multimodal real-world data collection
  • Direct engagement with 5 million individuals
  • Longitudinal patient-level data
  • Integration of clinical, demographic, patient-reported, molecular, and digital data
  • 20+ condition-specific data collection cohorts
  • Support for research, discovery, and early development
  • Evidence generation and medical value demonstration
  • Commercial planning and market strategy insights
  • Privacy-first, consent-based foundation
  • Extensive publication record and industry partnerships

Use Cases

  • Measuring subtle changes in disease progression
  • Informing target selection and model development in translational research
  • Generating patient-centered evidence on outcomes and treatment effects
  • Understanding unmet needs and treatment patterns for commercial strategy
  • Tracking longitudinal experience and outcomes across chronic conditions
  • Recruitment and activation for prospective studies

What Physicians Need to Know

Real-World Evidence Analysis
Evidation Health specializes in generating real-world evidence (RWE) by collecting continuous, multimodal data directly from individuals. This data includes information from wearables, health apps, surveys, patient-reported outcomes, and clinical data (EHR and claims). They use this RWE to understand disease progression, treatment behavior, and outcomes, supporting research, evidence generation, and commercial decision-making.
Clinical Trial Matching
Evidation matches individuals to relevant research and clinical trial opportunities based on their health factors and preferences. They aim to make participation easier by pre-screening participants using real-world data and engaging them when behaviors or conditions indicate readiness.
Genomic Data Integration
Evidation's temporal biospecimen collection platform supports multiomics research in real-world settings, including genomic and proteomic testing from at-home biosamples. This is used to develop novel multimodal datasets for biomarker discovery and treatment-response modeling, particularly in autoimmune research.
Target Identification
Evidation's platform helps inform target selection and translational research by measuring subtle changes in disease progression and variability using data captured directly from individuals. They also identify and describe target patients based on real-world behaviors and disease impact.
Safety Signal Detection
While Evidation's core focus is on real-world data and evidence generation, AI tools in drug development, which Evidation contributes to through its data collection, can optimize trial designs and monitor safety signals across large datasets.
Collaboration Features
Evidation partners with life sciences companies, healthcare providers, and research institutions to leverage its platform for evidence-based solutions and insights into patient behavior. They also collaborate to expand real-world data utilization by enabling easier consent and sharing of diverse health data.
Publication Support
Evidation supports the generation of patient-centered evidence to support publications and value demonstration. They have supported over 100 peer-reviewed publications.
Physician Tip

Physicians can leverage Evidation Health's real-world data and evidence to gain a more comprehensive understanding of how treatments and diseases impact patients in their daily lives, beyond episodic clinic visits. The platform's ability to integrate data from wearables, patient-reported outcomes, and EHRs can provide valuable longitudinal insights into disease progression, treatment adherence, and quality of life. This can inform clinical decision-making, identify unmet patient needs, and contribute to the development of more patient-centered care strategies. When considering clinical trials, Evidation's matching capabilities can help identify suitable patients for studies, potentially accelerating research and ensuring more representative cohorts.

Evidation Health integrates with a variety of data sources, including wearable devices (e.g., Fitbit, Apple Health, Google Fit, Samsung Health, Oura), health apps, and electronic health records (EHRs) and claims data through partnerships like 1upHealth. This allows for the collection of continuous, multimodal real-world data.

Details

Category Drug Discovery & Research, Population Health Analytics, Wearables & Remote Monitoring (RPM)
Pricing Unknown
  • Evidation utilizes a software-as-a-service (SaaS) model for its customers
  • For individuals, the Evidation app rewards users with points for healthy activities, which can be redeemed for cash ($10 for every 10,000 points) or gift cards
Free Trial No
DeploymentCloud, Mobile App
Mobile App1
API AvailableUnknown
Data ExportUnknown
LanguagesEnglish
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Not applicable AI-estimated

Evidation's website mentions FDA 21 CFR Part 1 compliance, but does not explicitly state FDA clearance for its platform or specific offerings.

GDPRUnknown AI-estimated
Integrations
EHR Not specified
Specialties Autoimmune, Cardiology Ai, Dermatology Ai, Endocrinology Metabolic Ai, Neurology Ai, Oncology Ai

Social Proof

Customers5 million individuals in its community, 13 of the 15 largest life sciences companies
Notable
Leaders in life sciences (specific names not provided)

What the Web Says

Evidation Health is a technology and services company that focuses on understanding and influencing everyday behaviors for better health outcomes. They operate a health rewards app that compensates users for tracking activities like steps, sleep, and meals, as well as participating in health surveys and research studies. Evidation partners with healthcare organizations and researchers to collect anonymized real-world health data, which is then used for medical research and to develop new health interventions.

Overall: Mixed

Strengths

  • Earns passive income for health data already being tracked.
  • Integrates with over 20 popular health apps and devices (e.g., Apple Health, Google Fit, Fitbit).
  • Offers opportunities to participate in paid clinical trials and research studies.
  • User-friendly interface and automatic activity tracking.
  • Contributes to medical research and understanding of various health conditions.
  • Transparent about how health information is used and emphasizes user privacy and control.

Limitations

  • Earnings are generally modest, with many users reporting around $10-$30 per year from passive activity.
  • Payouts can be slow, taking several months to a year to reach the $10 minimum.
  • Some users report glitches with data syncing from connected apps and issues with surveys not awarding points.
  • Recent changes to the points system have reduced earning potential for some users.
  • Customer service has been described as unhelpful in some instances.
  • Primarily designed for US users, with full earning potential and payout options focused there.

Based on reviews from: Rannkly, Reddit, Visu Network, Fitcoin, Indeed.com, Apple App Store, YouTube (Evidation App Review - What to Know (Explained)), YouTube (App Review: Achievement (Now called Evidation!) | RunningGeekGirl), HealthVerity, Trustpilot, Evidation (Published Research), Evidation (Real-World Health Data), G2, PaidFromSurveys.com, Evidation (Health Research Studies on Evidation), BBB Business Profile, Evidation (Research Highlights), DEMONSTRATING VALUE: EVIDATION HEALTH, The future of digital health and Evidation's role in it, YouTube (Evidation App Review - Will They Really Pay You To Exercise?)

Last updated: 2026-09-13

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Evidation Health

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Evidation
Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
Evidation announced new insights from longitudinal surveys indicating rapid but uneven growth in the GLP-1 and prescription weight management market, with GLP-1 use rising from 9% to 12% among individuals actively trying to lose weight between May 2025 and May 2026.
2026-07
Evidation
Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights
Evidation launched a new dermatology cohort to understand treatment journeys for conditions like atopic dermatitis, psoriasis, and acne, revealing that consumer health products are crucial in how individuals manage their skin conditions.
2026-03
Evidation
Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research
Evidation introduced a temporal biospecimen collection platform to support multiomics research in real-world settings, starting with an autoimmune research cohort that includes proteomics sampling to advance the study of immune system dynamics.
2026-01
Evidation
Evidation Appoints Leslie Oley Wilberforce as CEO
Leslie Oley Wilberforce has been appointed as the new CEO of Evidation, where she will lead the company's growth in interactive real-world data and health research.
2025-03
Evidation
Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer
Dr. Ghazanfar Khan has been appointed as Chief Medical Officer at Evidation, where he will drive the clinical strategy for direct-to-participant multimodal data collection to fuel AI-powered discovery and evidence generation.
2025-12
Business Wire
Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals
Evidation's research from over 60,000 individuals in a cardiometabolic health and weight management cohort revealed that nearly 1 in 7 injectable GLP-1 users are microdosing, often due to patient-driven decisions to manage tolerability, reduce costs, or transition to weight maintenance.
2025-12
Evidation
Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research
Evidation and 1upHealth announced a long-term partnership to advance patient-centered, real-world health research by enabling consented data sharing and linkage of diverse real-world data sources, including health record data and data collected directly from individuals.
2024-10
Evidation
GLP-1 Use Is Growing, but Adoption Is Uneven
New insights from Evidation explore the factors shaping GLP-1 treatment access and adoption, including cost, coverage, information, and real-world experience, among individuals actively trying to lose weight.
2026-08

Videos

Product demos, reviews, and walkthroughs for Evidation Health.

View all on YouTube

Frequently Asked Questions

Evidation Health utilizes a variety of methods to ensure data accuracy, including integrating data from multiple sources like wearables, electronic health records, and patient-reported outcomes. They employ robust data validation techniques and sophisticated algorithms to identify and mitigate potential biases or inaccuracies in the collected real-world data, making it more reliable for drug discovery.
Evidation Health focuses on engaging patients in their natural environments, which can contribute to higher compliance. They leverage personalized nudges, gamification, and clear communication within their app to encourage consistent participation. While specific rates vary by study, their approach aims to minimize the burden on patients and maximize adherence to study protocols.
Yes, there are other platforms and traditional methods for real-world data collection, such as observational studies and patient registries. Evidation Health differentiates itself by its focus on continuous, passive data collection from a diverse range of digital sources, its ability to generate novel digital biomarkers, and its expertise in engaging large patient populations outside of clinical settings.
Evidation Health prioritizes patient privacy and adheres to strict regulatory guidelines like HIPAA and GDPR. They employ advanced encryption, de-identification, and access controls to protect sensitive patient information. Data is aggregated and anonymized before being used for research purposes, ensuring individual patient identities are not revealed.
While real-world data offers valuable insights, limitations can include potential confounding factors not captured by digital tools, the generalizability of findings to broader populations, and the challenge of establishing direct causality. Physicians should interpret these findings as complementary to traditional clinical trial data, providing a broader understanding of drug effects in real-world settings rather than definitive proof of efficacy.
Yes, Evidation Health's platform is designed to identify novel patient populations and digital biomarkers. By continuously collecting and analyzing diverse real-world data, they can detect subtle patterns and changes in health behaviors and physiological metrics that may indicate disease onset, progression, or response to treatment, thereby informing new avenues for drug discovery.
The cost structure for pharmaceutical companies engaging with Evidation Health is typically project-based and can vary significantly depending on the scope, duration, and complexity of the research program. Factors influencing pricing include the size of the patient cohort, the types of data collected, the specific research questions being addressed, and the level of analytical support required.

Related Tools

MyTrials.ai
MyTrials.ai
Drug Discovery & Research
MyTrials.ai is an AI-powered platform for clinical trial recruitment, combining a verified patient network, intelligent matching, and human navigators to accelerate enrollment.
HypeCheck
2 Minute Medicine
Clinical Decision Support & Reference
HypeCheck™ instantly evaluates health articles, wellness advice, and viral trends by cross-referencing them directly against peer-reviewed literature on PubMed, active clinical trials, and official health agency guidance.
Scite
Scite
Drug Discovery & Research
Scite is an AI research tool that shows how papers have been cited, providing context on whether findings are supported or contradicted by subsequent research, which is valuable for medical writers and researchers.
Google Bard
Google
Clinical Decision Support & Reference
Google Bard, now known as Gemini, is a generative AI model that can assist healthcare professionals with tasks such as summarizing medical records and research papers, generating hypotheses, and providing information on medical conditions.
AIDDISON Explorer
Sigma-Aldrich (Merck KGaA)
Drug Discovery & Research
AIDDISSON Explorer is an AI-powered drug discovery platform combining generative AI with computer-aided drug design for molecular generation, virtual screening, ADMET prediction, and retrosynthesis planning.
Noodle Biomedical Literature Discovery
Helena Bioinformatics
Drug Discovery & Research
Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.

See all Drug Discovery & Research tools →

Suggest an Edit → | Last Verified: 2026-06-11 | First Added: 2026-06-11

Investors who backed Evidation Health

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.